Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report-Reference-Cited by-同舟云学术

Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report

Published:2019-02 Issue:2 Volume:25 Page:335-342
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sahebi Firoozeh,Garderet Laurent,Kanate Abraham S.,Eikema Diderik-Jan,Knelange Nina Simone,Alvelo Omar F. Dávila,Koc Yener,Blaise Didier,Bashir Qaiser,Moraleda José M.,Dreger Peter,Sanchez James F.,Ciurea Stefan^ORCID,Schouten Harry,Shah Nirav N.,Verbeek Mareike,Rösler Wolf,Diez-Martin Jose L.,Schoenland Stefan,D'Souza Anita,Kröger Nicolaus^ORCID,Hari Parameswaran^ORCID

Funder

American Society for Blood and Marrow Transplantation

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome;Avet-Loiseau;Blood,2007

2. Outcomes of salvage autologous versus allogeneic hematopoietic cell transplantation for relapsed multiple myeloma after initial autologous hematopoietic cell transplantation;Wirk;J Clin Med Res,2013

3. A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma;Rosiñol;Blood,2008

4. A comparison of allografting with autografting for newly diagnosed myeloma;Bruno;N Engl J Med,2007

5. Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting;Rotta;Blood,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation in multiple myeloma: is there still a place?;Frontiers in Oncology;2024-06-04

2. Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years;Anticancer Research;2022-12

3. Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study;Leukemia & Lymphoma;2022-08-01

4. Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma;Oncology and Therapy;2022-04-04

5. Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions;Oncology and Therapy;2022-02-01